anti cd57 fitc (Miltenyi Biotec)

Miltenyi Biotec is a verified supplier

Miltenyi Biotec manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Miltenyi Biotec anti cd57 fitc
Anti Cd57 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 51 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd57+fitc/CD57-FITC/us12416565-686-28-27
Average 94 stars, based on 51 article reviews

anti cd57 fitc - by Bioz Stars, 2026-09

94/100 stars

Images

other:

Article Title: Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping.
Article Snippet: The following antibodies were used in the screening panel: CD3-V500 (clone UCHT1), CD14-V500 (clone MφP9), CD19-V500 (clone HIB19) and Granzyme B-AF700 (clone GB11) from Beckton Dickinson; CD57-FITC (clone HNK-1), CD38-BV650 (clone HB-7) and CD158e1-BV421 (clone DX9) from BioLegend; CD158a-APC-Vio770 (clone REA284) and CD158a/h-PE-Vio770 (clone 11PB6) from Miltenyi Biotec; and CD158b1/b2,j-PE-Cy5.5 (clone GL183), CD159a-APC (clone Z199) and CD56-ECD (clone N901) from Beckman Coulter.

Article Title: The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration.
Article Snippet: Abs were purchased for CD56 BUV395, Granzyme B AF700, CD3 V500, CD14 V500, CD19 V500, and IFN-g allophycocyanin from BD Biosciences; CD56 ECD, KIR2DL2/S2/L3 PE-Cy5.5, and NKG2A allophycocyanin from Beckman Coulter Life Sciences; CD57 FITC, CD107 AF488, KIR3DL1 BV421 and BV711, GPR56 PE, GPR56 unconjugated, and LFA1 PE from BioLegend; and KIR2DL1 allophycocyanin-Vio 770 and KIR2DL1/S1 PE-Vio770 from Miltenyi Biotec.

Article Title: The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITA
Article Snippet: The following antibodies were used: HLA-DP-BV421 (B7/21, BD Biosciences, 750875), HLA-DP-APC (B7/21, Leinco Technologies, H240), HLA-DP-PE (B7/21, BD Biosciences, 566825), HLA-DR-PE (L243, BD Biosciences, 347401), HLA-DQ-PE (HLADQ1, BioLegend, 318106), HLA-DM-PE (MaP.DM1, BD Biosciences, 555983), CD137-APC (4B4-1, BD Biosciences, 561702), CD4-PE-Cy7 (SK3, BD Biosciences, 557852), CD8-Pacific Blue (B9.11, Beckman Coulter, B49182 ), CD3-Krome Orange (UCHT1, Beckman Coulter, B00068 ), CD57-FITC (TB03, Miltenyi Biotec, 130-122-935), CD14-FITC (MφP9, BD Biosciences, 345784), CD19-APC (HIB19, BD Biosciences, 555415), CD56-PE (N901, Beckman Coulter, A07788).

Article Title: The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T-cell recognition by targeting CIITA
Article Snippet: The following antibodies were used: HLA-DP-BV421 (B7/21, BD Biosciences, 750875), HLA-DP-APC (B7/21, Leinco Technologies, H240), HLA-DP-PE (B7/21, BD Biosciences, 566825), HLA-DR-PE (L243, BD Biosciences, 347401), HLA-DQ-PE (HLADQ1, BioLegend, 318106), HLA-DM-PE (MaP.DM1, BD Biosciences, 555983), CD137-APC (4B4-1, BD Biosciences, 561702), CD4-PE-Cy7 (SK3, BD Biosciences, 557852), CD8-Pacific Blue (B9.11, Beckman Coulter, B49182), CD3-Krome Orange (UCHT1, Beckman Coulter, B00068), CD57-FITC (TB03, Miltenyi Biotec, 130-122-935).

Article Title: Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping
Article Snippet: The following antibodies were used in the screening panel: CD3-V500 (UCHT1), CD14-V500 (MφP9), CD19-V500 (HIB19), Granzyme B-AF700 (GB11) from Beckton Dickinson; CD57-FITC (HNK-1), CD38-BV650 (HB-7), KIR3DL1-BV421 (DX9) from BioLegend; KIR2DL1-APC-Cy7 (REA284), CD158a,h-PE-Cy7 (11PB6), from Miltenyi Biotec; CD158b1/b2,j-PE-Cy5.5 (GL183), NKG2A-APC (Z199), CD56-ECD (N901) from Beckman Coulter.

Incubation:

Article Title: Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells
Article Snippet: .. After incubation, we performed immunophenotyping of functionally relevant receptors within the NK subpopulations with TIGIT PE-Vio770, CD69 BV421, TACTILE BV421 (Biolegend), CD56 AlexaFluor770, CD16 APC-Cy7, CD25 FITC, DNAM-1 PE, CXCR4 APC, NKG2D BV421, KIR3DL1 PE-Vio770, KIR2DL2/L3/S2 FITC, KIR3DL2 PE (BD Biosciences), NKp46 FITC, NKp44 PE, NKp30 APC, CD57 FITC, KIR2DS4 PE, NKG2A PE-Vio615, PD-1 FITC, LAG-3 PE, TIM-3 PE-Vio770, KIR2DL4 APC, KIR2DL1 BV421, CD3 Viogreen (Miltenyi Biotec), and NKG2C APC (R&D Systems). .. We acquired samples in a Navios flow cytometer (Beckman Coulter) and employed FlowJo v10.0.7 software (BD Biosciences) for the data analysis.

Staining:

Article Title: Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires
Article Snippet: For the secondary staining of the biotin-conjugated antibodies, we used a streptavidin-BV421 conjugated antibody (RRID:AB_2869475, BD Biosciences) or a streptavidin-BV650 (BD Biosciences). .. Surface staining with anti-CD56- ECD, NKG2A-APC, GL183-Pe-Cy5.5 (Beckman coulter), CD57-FITC, DX9-BV421 (Biolegend), EB6- Pe-Cy7 and KIR2DL1-APCCy7 (Miltenyi) was performed prior to sorting. .. Data were analyzed in FlowJo version 10.8.1 (TreeStar, Inc.).

Flow Cytometry:

Article Title: Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.
Article Snippet: Depletion of CD57+ cells was performed per manufacturer’s protocol using human anti-CD57 MicroBeads (Miltenyi Biotec). .. The efficacy of the depletion was assessed by flow cytometry using CD3 PerCP (clone SK7; BD Biosciences), CD56 PE-Cy7 (clone NCAM16.2; BD Biosciences) and CD57 FITC (clone TB03; Miltenyi Biotec) antibodies. .. Cells were acquired on an LSR Fortessa flow cytometer (BD Biosciences) and data were analyzed using FlowJo software (FlowJo LLC).

Review